Identification of JPX-RABEP1 Pair as an Immune-Related Biomarker and Therapeutic Target in Pulmonary Arterial Hypertension by Bioinformatics and Experimental Analyses
Open Access
- 8 December 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (24) , 15559
Abstract
Pulmonary arterial hypertension (PAH) is a pulmonary vascular disease characterized by pulmonary vascular remodeling and right heart enlargement the pathogenesis of PAH is complicated; no biologic-based therapy is available for the treatment of PAH, but recent studies suggest that inflammatory response and abnormal proliferation of pulmonary artery smooth muscle cells are the main pathogenic mechanism, while the role of immune-related long non-coding RNAs (lncRNAs) remains unclear. The aim of this study was to systematically analyze immune-related lncRNAs in PAH. Here, we downloaded a publicly available microarray data from PAH and control patients (GSE113439). A total of 243 up-regulated and 203 down-regulated differentially expressed genes (DEGs) were screened, and immune-related DEGs were further obtained from ImmPort. The immune-related lncRNAs were obtained by co-expression analysis of immune-related mRNAs. Then, immune-related lncRNAs-mRNAs network including 2 lncRNAs and 6 mRNAs was constructed which share regulatory miRNAs and have significant correlation. Among the lncRNA-mRNA pairs, one pair (JPX-RABEP1) was verified in the validating dataset GSE53408 and PAH mouse model. Furthermore, the immune cell infiltration analysis of the GSE113439 dataset revealed that the JPX-RABEP1 pair may participate in the occurrence and development of PAH through immune cell infiltration. Together, our findings reveal that the lncRNA-mRNA pair JPX-RABEP1 may be a novel biomarker and therapeutic target for PAH.Keywords
Funding Information
- National Natural Science Foundation of China (81941003, 32270884)
- National Key Research and Development Program of China (2021YFA0805902, 2019YFE0117400)
- Key Research and Development Program of Zhejiang Province (2021C02060)
This publication has 38 references indexed in Scilit:
- T ranslational A dvances in the F ield of P ulmonary H ypertension Bench to Bedside: How Fundamental Discoveries in Science Are Advancing Our Understanding and Therapy of Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2017
- A global view of pulmonary hypertensionThe Lancet Respiratory Medicine, 2016
- Metabolomic Heterogeneity of Pulmonary Arterial HypertensionPLOS ONE, 2014
- The multilayered complexity of ceRNA crosstalk and competitionNature, 2014
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresBioinformatics, 2013
- Jpx RNA Activates Xist by Evicting CTCFCell, 2013
- Long Noncoding RNAs: Cellular Address Codes in Development and DiseaseCell, 2013
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- The Long Noncoding RNA, Jpx, Is a Molecular Switch for X Chromosome InactivationCell, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009